Treatment with Dalteparin is Associated with a Lower Risk of Bleeding Compared to Treatment with Unfractionated Heparin in Patients with ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2016-02

AUTHORS

Doyun Park, William Southern, Manuela Calvo, Margarita Kushnir, Clemencia Solorzano, Mark Sinnet, Henny H. Billett

ABSTRACT

BACKGROUND: Low molecular weight heparins (LMWHs) have been cautiously used in patients with chronic kidney disease (CKD) due to fear of accumulation. Dalteparin, however, has shown minimal tendency to accumulate in patients with CKD and may be safe to use in this patient population. OBJECTIVE: We compared the incidence of clinically significant bleeding in patients with CKD receiving therapeutic doses of dalteparin to that of patients with CKD receiving therapeutic doses of UFH. DESIGN: This was a retrospective cohort study. SUBJECTS: Inpatients with CKD (GFR < 60 ml/min) who were treated with therapeutic dalteparin or UFH were included in the study MAIN MEASURES: Primary outcome was major bleeding within 10 days of anticoagulation, identified by ICD-9 code and confirmed by chart review. Demographic characteristics, laboratory values, comorbidities, prior bleeding history and inpatient medications were extracted for each admission from the electronic medical record. Logistic regression models were created to examine the association between choice of anticoagulant and bleeding rates, after adjustment for demographic and clinical characteristics. KEY RESULTS: Dalteparin-treated patients were significantly less likely to experience a major bleed than patients treated with UFH (1.14 % vs. 3.49 %, p < 0.001). The reduced likelihood of bleeding associated with dalteparin treatment remained significant after adjustment for patient characteristics (HR 0.39, 95 % CI: 0.21-0.70, p < 0.0001). A stratified analysis for subgroups with GFR< 30 mL/min and with GFR between 30 and 60 mL/min showed that dalteparin was still associated with lower odds of bleeding compared to treatment with unfractionated heparin, but the difference was nonsignificant for GFR< 30 (HR 0.35, 95 % CI: 0.11-1.15), even after adjustment (OR 0.37, 95 % CI: 0.11-1.22). CONCLUSION: In patients with CKD, treatment with therapeutic dose dalteparin was associated with lower rates of bleeding than treatment with unfractionated heparin. For patients with severe CKD (GFR< 30), dalteparin was shown to be at least as safe as unfractionated heparin. More... »

PAGES

182-187

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11606-015-3466-4

DOI

http://dx.doi.org/10.1007/s11606-015-3466-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1016681515

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/26209179


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anticoagulants", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dalteparin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glomerular Filtration Rate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hemorrhage", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Heparin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Renal Insufficiency, Chronic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "St. Luke's-Roosevelt Hospital Center", 
          "id": "https://www.grid.ac/institutes/grid.240873.a", 
          "name": [
            "Division of Hematology-Oncology, Mount Sinai-Roosevelt Hospital, 1000 Tenth Avenue, New York, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Park", 
        "givenName": "Doyun", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Montefiore Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.240283.f", 
          "name": [
            "Division of Hospital Medicine, Department of Medicine, Montefiore Medical Center of Albert Einstein College of Medicine, Bronx, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Southern", 
        "givenName": "William", 
        "id": "sg:person.0774155445.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0774155445.28"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Montefiore Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.240283.f", 
          "name": [
            "Division of Hospital Medicine, Department of Medicine, Montefiore Medical Center of Albert Einstein College of Medicine, Bronx, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Calvo", 
        "givenName": "Manuela", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Montefiore Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.240283.f", 
          "name": [
            "Division of Hematology, Department of Oncology, Montefiore Medical Center of the Albert Einstein College of Medicine, Bronx, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kushnir", 
        "givenName": "Margarita", 
        "id": "sg:person.01021065545.87", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01021065545.87"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Montefiore Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.240283.f", 
          "name": [
            "Department of Pharmacy, Montefiore Medical Center, Bronx, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Solorzano", 
        "givenName": "Clemencia", 
        "id": "sg:person.016315375717.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016315375717.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Montefiore Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.240283.f", 
          "name": [
            "Department of Pharmacy, Montefiore Medical Center, Bronx, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sinnet", 
        "givenName": "Mark", 
        "id": "sg:person.01067760530.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01067760530.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Montefiore Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.240283.f", 
          "name": [
            "Division of Hematology, Department of Oncology, Montefiore Medical Center of the Albert Einstein College of Medicine, Bronx, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Billett", 
        "givenName": "Henny H.", 
        "id": "sg:person.01204633365.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01204633365.24"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1111/j.1538-7836.2005.01204.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002271079"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12603-012-0072-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004367916", 
          "https://doi.org/10.1007/s12603-012-0072-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.amjmed.2012.09.021", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004513655"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2125.2004.02253.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004545046"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.2014.65", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005065995"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00002018-200528040-00005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007256967", 
          "https://doi.org/10.2165/00002018-200528040-00005"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00002018-200528040-00005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007256967", 
          "https://doi.org/10.2165/00002018-200528040-00005"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.amjmed.2009.04.027", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008026002"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jcrc.2005.09.009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012163227"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1067/mhj.2002.120774", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015160237"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40138-013-0014-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019723773", 
          "https://doi.org/10.1007/s40138-013-0014-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa025313", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024707641"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1592/phco.2005.25.6.817", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027595323"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1592/phco.2005.25.6.817", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027595323"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/2162-3619-2-21", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029465880", 
          "https://doi.org/10.1186/2162-3619-2-21"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pone.0106517", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029545960"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1378/chest.11-2295", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030538705"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/2013.jamainternmed.369", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033665283"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00002018-200225100-00005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040871380", 
          "https://doi.org/10.2165/00002018-200225100-00005"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00002018-200225100-00005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040871380", 
          "https://doi.org/10.2165/00002018-200225100-00005"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1378/chest.125.3.856", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046132787"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199709043371007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046598363"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/0091270003253420", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048041623"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1538-7836.2009.03292.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049397481"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ahj.2007.12.006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052491238"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0049-3848(02)00031-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053672590"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7326/0003-4819-144-9-200605020-00011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073708729"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1055/s-0037-1614119", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074741643"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077251566", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1055/s-0038-1651032", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1079025594"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1055/s-0038-1646018", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1079414239"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1055/s-0038-1653833", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082385609"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1055/s-0038-1648851", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082527240"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2016-02", 
    "datePublishedReg": "2016-02-01", 
    "description": "BACKGROUND: Low molecular weight heparins (LMWHs) have been cautiously used in patients with chronic kidney disease (CKD) due to fear of accumulation. Dalteparin, however, has shown minimal tendency to accumulate in patients with CKD and may be safe to use in this patient population.\nOBJECTIVE: We compared the incidence of clinically significant bleeding in patients with CKD receiving therapeutic doses of dalteparin to that of patients with CKD receiving therapeutic doses of UFH.\nDESIGN: This was a retrospective cohort study.\nSUBJECTS: Inpatients with CKD (GFR\u2009<\u200960\u00a0ml/min) who were treated with therapeutic dalteparin or UFH were included in the study\nMAIN MEASURES: Primary outcome was major bleeding within 10\u00a0days of anticoagulation, identified by ICD-9 code and confirmed by chart review. Demographic characteristics, laboratory values, comorbidities, prior bleeding history and inpatient medications were extracted for each admission from the electronic medical record. Logistic regression models were created to examine the association between choice of anticoagulant and bleeding rates, after adjustment for demographic and clinical characteristics.\nKEY RESULTS: Dalteparin-treated patients were significantly less likely to experience a major bleed than patients treated with UFH (1.14\u00a0% vs. 3.49\u00a0%, p\u2009<\u20090.001). The reduced likelihood of bleeding associated with dalteparin treatment remained significant after adjustment for patient characteristics (HR 0.39, 95\u00a0% CI: 0.21-0.70, p\u2009<\u20090.0001). A stratified analysis for subgroups with GFR< 30\u00a0mL/min and with GFR between 30 and 60\u00a0mL/min showed that dalteparin was still associated with lower odds of bleeding compared to treatment with unfractionated heparin, but the difference was nonsignificant for GFR< 30 (HR 0.35, 95\u00a0% CI: 0.11-1.15), even after adjustment (OR 0.37, 95\u00a0% CI: 0.11-1.22).\nCONCLUSION: In patients with CKD, treatment with therapeutic dose dalteparin was associated with lower rates of bleeding than treatment with unfractionated heparin. For patients with severe CKD (GFR< 30), dalteparin was shown to be at least as safe as unfractionated heparin.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s11606-015-3466-4", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2705247", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1096256", 
        "issn": [
          "0884-8734", 
          "1525-1497"
        ], 
        "name": "Journal of General Internal Medicine", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "31"
      }
    ], 
    "name": "Treatment with Dalteparin is Associated with a Lower Risk of Bleeding Compared to Treatment with Unfractionated Heparin in Patients with Renal Insufficiency", 
    "pagination": "182-187", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "4f7b2a50030e72ae129f63c67c05a234abc6c6eadf260da846eff335b7142cce"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "26209179"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8605834"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11606-015-3466-4"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1016681515"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11606-015-3466-4", 
      "https://app.dimensions.ai/details/publication/pub.1016681515"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T12:11", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000361_0000000361/records_53981_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs11606-015-3466-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11606-015-3466-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11606-015-3466-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11606-015-3466-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11606-015-3466-4'


 

This table displays all metadata directly associated to this object as RDF triples.

262 TRIPLES      21 PREDICATES      72 URIs      34 LITERALS      22 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11606-015-3466-4 schema:about N23c392a53f494918898860a54366dcc6
2 N2fe46ed902b24883a9770f20b09b139f
3 N3339c6360a7b4add8445c9d0641bc5e3
4 N56c77137b35e4716bdf862919abf102b
5 N58129782e46c4457bf9bc0992c9b137e
6 N67be7a50321a43919b13c66b87cace5d
7 N8920311297d545e4b871f50423bacdee
8 N9222d1a43a6d456ea927da7001d73d94
9 Na4df5b0e2f5740cfa942c44101e368f9
10 Na8eb709482e9445983b7a424fd0256d5
11 Nad9fe89c98d54f88925b956b1b38c421
12 Nc12434d2e6c84c9e8a6f34d4f8be89c8
13 Nea86d55127f14548a111f39e7e7d492c
14 anzsrc-for:11
15 anzsrc-for:1103
16 schema:author N754849a02f364fe384756951c90cc2e8
17 schema:citation sg:pub.10.1007/s12603-012-0072-6
18 sg:pub.10.1007/s40138-013-0014-6
19 sg:pub.10.1186/2162-3619-2-21
20 sg:pub.10.2165/00002018-200225100-00005
21 sg:pub.10.2165/00002018-200528040-00005
22 https://app.dimensions.ai/details/publication/pub.1077251566
23 https://doi.org/10.1001/2013.jamainternmed.369
24 https://doi.org/10.1001/jama.2014.65
25 https://doi.org/10.1016/j.ahj.2007.12.006
26 https://doi.org/10.1016/j.amjmed.2009.04.027
27 https://doi.org/10.1016/j.amjmed.2012.09.021
28 https://doi.org/10.1016/j.jcrc.2005.09.009
29 https://doi.org/10.1016/s0049-3848(02)00031-2
30 https://doi.org/10.1055/s-0037-1614119
31 https://doi.org/10.1055/s-0038-1646018
32 https://doi.org/10.1055/s-0038-1648851
33 https://doi.org/10.1055/s-0038-1651032
34 https://doi.org/10.1055/s-0038-1653833
35 https://doi.org/10.1056/nejm199709043371007
36 https://doi.org/10.1056/nejmoa025313
37 https://doi.org/10.1067/mhj.2002.120774
38 https://doi.org/10.1111/j.1365-2125.2004.02253.x
39 https://doi.org/10.1111/j.1538-7836.2005.01204.x
40 https://doi.org/10.1111/j.1538-7836.2009.03292.x
41 https://doi.org/10.1177/0091270003253420
42 https://doi.org/10.1371/journal.pone.0106517
43 https://doi.org/10.1378/chest.11-2295
44 https://doi.org/10.1378/chest.125.3.856
45 https://doi.org/10.1592/phco.2005.25.6.817
46 https://doi.org/10.7326/0003-4819-144-9-200605020-00011
47 schema:datePublished 2016-02
48 schema:datePublishedReg 2016-02-01
49 schema:description BACKGROUND: Low molecular weight heparins (LMWHs) have been cautiously used in patients with chronic kidney disease (CKD) due to fear of accumulation. Dalteparin, however, has shown minimal tendency to accumulate in patients with CKD and may be safe to use in this patient population. OBJECTIVE: We compared the incidence of clinically significant bleeding in patients with CKD receiving therapeutic doses of dalteparin to that of patients with CKD receiving therapeutic doses of UFH. DESIGN: This was a retrospective cohort study. SUBJECTS: Inpatients with CKD (GFR < 60 ml/min) who were treated with therapeutic dalteparin or UFH were included in the study MAIN MEASURES: Primary outcome was major bleeding within 10 days of anticoagulation, identified by ICD-9 code and confirmed by chart review. Demographic characteristics, laboratory values, comorbidities, prior bleeding history and inpatient medications were extracted for each admission from the electronic medical record. Logistic regression models were created to examine the association between choice of anticoagulant and bleeding rates, after adjustment for demographic and clinical characteristics. KEY RESULTS: Dalteparin-treated patients were significantly less likely to experience a major bleed than patients treated with UFH (1.14 % vs. 3.49 %, p < 0.001). The reduced likelihood of bleeding associated with dalteparin treatment remained significant after adjustment for patient characteristics (HR 0.39, 95 % CI: 0.21-0.70, p < 0.0001). A stratified analysis for subgroups with GFR< 30 mL/min and with GFR between 30 and 60 mL/min showed that dalteparin was still associated with lower odds of bleeding compared to treatment with unfractionated heparin, but the difference was nonsignificant for GFR< 30 (HR 0.35, 95 % CI: 0.11-1.15), even after adjustment (OR 0.37, 95 % CI: 0.11-1.22). CONCLUSION: In patients with CKD, treatment with therapeutic dose dalteparin was associated with lower rates of bleeding than treatment with unfractionated heparin. For patients with severe CKD (GFR< 30), dalteparin was shown to be at least as safe as unfractionated heparin.
50 schema:genre research_article
51 schema:inLanguage en
52 schema:isAccessibleForFree true
53 schema:isPartOf N797c242aa1f94c9bb2a7ec4bd26aa2d1
54 Nf789f96d3a7b412eba0db221db2c5f6d
55 sg:journal.1096256
56 schema:name Treatment with Dalteparin is Associated with a Lower Risk of Bleeding Compared to Treatment with Unfractionated Heparin in Patients with Renal Insufficiency
57 schema:pagination 182-187
58 schema:productId N40da401894d043e1aa83212de6433dbe
59 N44a852e7949b41d8ba0b6695f2d3efbf
60 N7226183ed559450b89596d8bb5a37338
61 Na43c0c437f5545eda62d8ca0e05dd37d
62 Nc797637737e647dcb8e99aa298e8e98c
63 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016681515
64 https://doi.org/10.1007/s11606-015-3466-4
65 schema:sdDatePublished 2019-04-11T12:11
66 schema:sdLicense https://scigraph.springernature.com/explorer/license/
67 schema:sdPublisher N971e3526fd854941a1341ba6d0e01006
68 schema:url http://link.springer.com/10.1007%2Fs11606-015-3466-4
69 sgo:license sg:explorer/license/
70 sgo:sdDataset articles
71 rdf:type schema:ScholarlyArticle
72 N05652547f3a84b17803dcd0687be332d rdf:first sg:person.01067760530.45
73 rdf:rest Nbaf85f9709cd46dca678867df0344ff8
74 N23c392a53f494918898860a54366dcc6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
75 schema:name Anticoagulants
76 rdf:type schema:DefinedTerm
77 N2fe46ed902b24883a9770f20b09b139f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Female
79 rdf:type schema:DefinedTerm
80 N3339c6360a7b4add8445c9d0641bc5e3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Aged, 80 and over
82 rdf:type schema:DefinedTerm
83 N3ee9ed894f7942f9b3844d10febf603c rdf:first N61f6ed84aa54435ea833cc65a5b2446c
84 rdf:rest Ncdb5ba78a6724c958bf3d47f797e7e5e
85 N40da401894d043e1aa83212de6433dbe schema:name doi
86 schema:value 10.1007/s11606-015-3466-4
87 rdf:type schema:PropertyValue
88 N44a852e7949b41d8ba0b6695f2d3efbf schema:name dimensions_id
89 schema:value pub.1016681515
90 rdf:type schema:PropertyValue
91 N56c77137b35e4716bdf862919abf102b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Glomerular Filtration Rate
93 rdf:type schema:DefinedTerm
94 N58129782e46c4457bf9bc0992c9b137e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Dalteparin
96 rdf:type schema:DefinedTerm
97 N61f6ed84aa54435ea833cc65a5b2446c schema:affiliation https://www.grid.ac/institutes/grid.240283.f
98 schema:familyName Calvo
99 schema:givenName Manuela
100 rdf:type schema:Person
101 N67be7a50321a43919b13c66b87cace5d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Retrospective Studies
103 rdf:type schema:DefinedTerm
104 N7226183ed559450b89596d8bb5a37338 schema:name nlm_unique_id
105 schema:value 8605834
106 rdf:type schema:PropertyValue
107 N754849a02f364fe384756951c90cc2e8 rdf:first Nc6b2d98bb359482d894cf7d83abef157
108 rdf:rest Ne718a51b35ce483e9df4db092e5bfd14
109 N797c242aa1f94c9bb2a7ec4bd26aa2d1 schema:issueNumber 2
110 rdf:type schema:PublicationIssue
111 N8920311297d545e4b871f50423bacdee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Heparin
113 rdf:type schema:DefinedTerm
114 N9222d1a43a6d456ea927da7001d73d94 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Hemorrhage
116 rdf:type schema:DefinedTerm
117 N971e3526fd854941a1341ba6d0e01006 schema:name Springer Nature - SN SciGraph project
118 rdf:type schema:Organization
119 Na43c0c437f5545eda62d8ca0e05dd37d schema:name readcube_id
120 schema:value 4f7b2a50030e72ae129f63c67c05a234abc6c6eadf260da846eff335b7142cce
121 rdf:type schema:PropertyValue
122 Na4df5b0e2f5740cfa942c44101e368f9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Humans
124 rdf:type schema:DefinedTerm
125 Na8eb709482e9445983b7a424fd0256d5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Aged
127 rdf:type schema:DefinedTerm
128 Nad9fe89c98d54f88925b956b1b38c421 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Renal Insufficiency, Chronic
130 rdf:type schema:DefinedTerm
131 Nbaf85f9709cd46dca678867df0344ff8 rdf:first sg:person.01204633365.24
132 rdf:rest rdf:nil
133 Nc12434d2e6c84c9e8a6f34d4f8be89c8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Male
135 rdf:type schema:DefinedTerm
136 Nc6b2d98bb359482d894cf7d83abef157 schema:affiliation https://www.grid.ac/institutes/grid.240873.a
137 schema:familyName Park
138 schema:givenName Doyun
139 rdf:type schema:Person
140 Nc797637737e647dcb8e99aa298e8e98c schema:name pubmed_id
141 schema:value 26209179
142 rdf:type schema:PropertyValue
143 Ncdb5ba78a6724c958bf3d47f797e7e5e rdf:first sg:person.01021065545.87
144 rdf:rest Ndd2d2271452f42beb422bf134c5d11f5
145 Ndd2d2271452f42beb422bf134c5d11f5 rdf:first sg:person.016315375717.26
146 rdf:rest N05652547f3a84b17803dcd0687be332d
147 Ne718a51b35ce483e9df4db092e5bfd14 rdf:first sg:person.0774155445.28
148 rdf:rest N3ee9ed894f7942f9b3844d10febf603c
149 Nea86d55127f14548a111f39e7e7d492c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Middle Aged
151 rdf:type schema:DefinedTerm
152 Nf789f96d3a7b412eba0db221db2c5f6d schema:volumeNumber 31
153 rdf:type schema:PublicationVolume
154 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
155 schema:name Medical and Health Sciences
156 rdf:type schema:DefinedTerm
157 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
158 schema:name Clinical Sciences
159 rdf:type schema:DefinedTerm
160 sg:grant.2705247 http://pending.schema.org/fundedItem sg:pub.10.1007/s11606-015-3466-4
161 rdf:type schema:MonetaryGrant
162 sg:journal.1096256 schema:issn 0884-8734
163 1525-1497
164 schema:name Journal of General Internal Medicine
165 rdf:type schema:Periodical
166 sg:person.01021065545.87 schema:affiliation https://www.grid.ac/institutes/grid.240283.f
167 schema:familyName Kushnir
168 schema:givenName Margarita
169 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01021065545.87
170 rdf:type schema:Person
171 sg:person.01067760530.45 schema:affiliation https://www.grid.ac/institutes/grid.240283.f
172 schema:familyName Sinnet
173 schema:givenName Mark
174 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01067760530.45
175 rdf:type schema:Person
176 sg:person.01204633365.24 schema:affiliation https://www.grid.ac/institutes/grid.240283.f
177 schema:familyName Billett
178 schema:givenName Henny H.
179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01204633365.24
180 rdf:type schema:Person
181 sg:person.016315375717.26 schema:affiliation https://www.grid.ac/institutes/grid.240283.f
182 schema:familyName Solorzano
183 schema:givenName Clemencia
184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016315375717.26
185 rdf:type schema:Person
186 sg:person.0774155445.28 schema:affiliation https://www.grid.ac/institutes/grid.240283.f
187 schema:familyName Southern
188 schema:givenName William
189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0774155445.28
190 rdf:type schema:Person
191 sg:pub.10.1007/s12603-012-0072-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004367916
192 https://doi.org/10.1007/s12603-012-0072-6
193 rdf:type schema:CreativeWork
194 sg:pub.10.1007/s40138-013-0014-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019723773
195 https://doi.org/10.1007/s40138-013-0014-6
196 rdf:type schema:CreativeWork
197 sg:pub.10.1186/2162-3619-2-21 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029465880
198 https://doi.org/10.1186/2162-3619-2-21
199 rdf:type schema:CreativeWork
200 sg:pub.10.2165/00002018-200225100-00005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040871380
201 https://doi.org/10.2165/00002018-200225100-00005
202 rdf:type schema:CreativeWork
203 sg:pub.10.2165/00002018-200528040-00005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007256967
204 https://doi.org/10.2165/00002018-200528040-00005
205 rdf:type schema:CreativeWork
206 https://app.dimensions.ai/details/publication/pub.1077251566 schema:CreativeWork
207 https://doi.org/10.1001/2013.jamainternmed.369 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033665283
208 rdf:type schema:CreativeWork
209 https://doi.org/10.1001/jama.2014.65 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005065995
210 rdf:type schema:CreativeWork
211 https://doi.org/10.1016/j.ahj.2007.12.006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052491238
212 rdf:type schema:CreativeWork
213 https://doi.org/10.1016/j.amjmed.2009.04.027 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008026002
214 rdf:type schema:CreativeWork
215 https://doi.org/10.1016/j.amjmed.2012.09.021 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004513655
216 rdf:type schema:CreativeWork
217 https://doi.org/10.1016/j.jcrc.2005.09.009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012163227
218 rdf:type schema:CreativeWork
219 https://doi.org/10.1016/s0049-3848(02)00031-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053672590
220 rdf:type schema:CreativeWork
221 https://doi.org/10.1055/s-0037-1614119 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074741643
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1055/s-0038-1646018 schema:sameAs https://app.dimensions.ai/details/publication/pub.1079414239
224 rdf:type schema:CreativeWork
225 https://doi.org/10.1055/s-0038-1648851 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082527240
226 rdf:type schema:CreativeWork
227 https://doi.org/10.1055/s-0038-1651032 schema:sameAs https://app.dimensions.ai/details/publication/pub.1079025594
228 rdf:type schema:CreativeWork
229 https://doi.org/10.1055/s-0038-1653833 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082385609
230 rdf:type schema:CreativeWork
231 https://doi.org/10.1056/nejm199709043371007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046598363
232 rdf:type schema:CreativeWork
233 https://doi.org/10.1056/nejmoa025313 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024707641
234 rdf:type schema:CreativeWork
235 https://doi.org/10.1067/mhj.2002.120774 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015160237
236 rdf:type schema:CreativeWork
237 https://doi.org/10.1111/j.1365-2125.2004.02253.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1004545046
238 rdf:type schema:CreativeWork
239 https://doi.org/10.1111/j.1538-7836.2005.01204.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1002271079
240 rdf:type schema:CreativeWork
241 https://doi.org/10.1111/j.1538-7836.2009.03292.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1049397481
242 rdf:type schema:CreativeWork
243 https://doi.org/10.1177/0091270003253420 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048041623
244 rdf:type schema:CreativeWork
245 https://doi.org/10.1371/journal.pone.0106517 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029545960
246 rdf:type schema:CreativeWork
247 https://doi.org/10.1378/chest.11-2295 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030538705
248 rdf:type schema:CreativeWork
249 https://doi.org/10.1378/chest.125.3.856 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046132787
250 rdf:type schema:CreativeWork
251 https://doi.org/10.1592/phco.2005.25.6.817 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027595323
252 rdf:type schema:CreativeWork
253 https://doi.org/10.7326/0003-4819-144-9-200605020-00011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073708729
254 rdf:type schema:CreativeWork
255 https://www.grid.ac/institutes/grid.240283.f schema:alternateName Montefiore Medical Center
256 schema:name Department of Pharmacy, Montefiore Medical Center, Bronx, NY, USA
257 Division of Hematology, Department of Oncology, Montefiore Medical Center of the Albert Einstein College of Medicine, Bronx, NY, USA
258 Division of Hospital Medicine, Department of Medicine, Montefiore Medical Center of Albert Einstein College of Medicine, Bronx, NY, USA
259 rdf:type schema:Organization
260 https://www.grid.ac/institutes/grid.240873.a schema:alternateName St. Luke's-Roosevelt Hospital Center
261 schema:name Division of Hematology-Oncology, Mount Sinai-Roosevelt Hospital, 1000 Tenth Avenue, New York, NY, USA
262 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...